bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

The first five BlueBird satellites are on their way into orbit to exclusively bring satellite calling to smartphones.AST SpaceMobile and AT&T successfully launched the SpaceX Bluebird-1 rocket ...

The Eras Tour singer rose to fame after she was discovered performing in an iconic Nashville venue as a teenager. Ever the ...

The Bluebird Café has been Nashville’s premiere ... By Annie Reuter “For somebody to consider me to be a business icon is really crazy because, heck, I wasn’t all that good a businessperson ...

Blue Bird Corp. engages in the design and manufacture of school buses. It operates through the Bus and Parts segments. The Bus segment includes the manufacturing and assembly of school buses to be ...

AT&T's Head of Network Chris Sambar talks about the carrier's plan to use the BlueBird satellites to bring connectivity to phones. He also calls out SpaceX, a rival to AST SpaceMobile.

Modern life disrupts the circadian rhythms controlling our biology – increasing our risk of developing conditions ranging from diabetes to dementia. Lynne Peeples's new book The Inner Clock explores a ...

SOMERVILLE, Mass., August 28, 2024--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced that members of the management team will participate in fireside chats at the following ...

In a report released today, Sami Corwin from William Blair reiterated a Hold rating on Bluebird Bio (BLUE – Research Report). The company’s shares opened today at $0.95. According to TipRanks ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced that it received notices (the “notices”) on August 20, 2024 from The Nasdaq Stock Market LLC (“Nasdaq ...

While the debate now is over how much the Fed will cut at its September meeting, it's increasingly clear that interest rates are headed lower.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...